Darwin Global Management, Ltd. Insmed Inc Call Options Transaction History
Darwin Global Management, Ltd.
- $2.37 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding INSM
# of Institutions
605Shares Held
202MCall Options Held
2.84MPut Options Held
3.26M-
Vanguard Group Inc Valley Forge, PA17.6MShares$3.35 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$2.7 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$2.13 Billion0.13% of portfolio
-
Baker Bros. Advisors LP New York, NY7.71MShares$1.46 Billion7.87% of portfolio
-
Capital International Investors Los Angeles, CA7.48MShares$1.42 Billion0.14% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $25.7B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...